Drug Recall Lawyer Blog Round-Up :: Drug Recall Lawyer Blog

Home > AstraZeneca Conflicts of Interest GlaxoSmithKline Merck & Co. Seroquel Social Networking > Drug Recall Lawyer Blog Round-Up

« Previous | Home | Next »

Posted On: March 22, 2010 by Miller & Zois

Drug Recall Lawyer Blog Round-Up

| Share

Drug Recall Lawyer Blog Round-Up (03-22-10)

Here are this week’s stories:

Avandia: The MayoClinic investigated who authored articles supporting Avandia in medical journals, and discovered that 90% had ties to the manufacturer, GlaxoSmithKline (HT: FiercePharma).
Seroquel: Trial number one is won by AstraZeneca (see blogs here and here).
Zocor: FDA issues a new warning for Merck’s cholesterol drug Zocor (HT: Tom Lamb’s Drug Injury Watch).
Sanofi-Aventis: More on their lessons from the botched Facebook experiment (HT: Pharma Marketing Blog).

Happy Monday!

Posted by Miller & Zois | Permalink | Email This Post | Comments (0)

Posted In: AstraZeneca , Conflicts of Interest , GlaxoSmithKline , Merck & Co. , Seroquel , Social Networking

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

Name:

Email Address:

URL:

Remember personal info?

Comments:

« Previous | Home | Next »